Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Phivida Holdings Inc. PHVAF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
Phivida is a premier brand of cannabidiol ('CBD')-infused functional foods, beverages and clinical products that is poised for global distribution.


OTCQX:PHVAF - Post by User

Phivida Holdings Inc. > HODLING
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by MatrixDwelleron May 25, 2018 12:22pm
67 Views
Post# 28081232

RE:HODLING

RE:HODLING
pabaloo wrote: Lol here's a tip learn how to spell! Frighten stoners should spend there money on dope and stay out of giving the rest of us an education on what to buy on the market. Nice post.


That's funny. You probably use your and you're interchangably just like you use their and there.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities